Darvon Taken Off the Market

Xanodyne Pharmaceuticals has withdrawn Darvon®, Darvon-N®, and Darvocet® from the US market at the request of the FDA. Even in recommended doses, Darvon (propoxyphene) can cause changes in heart activity which can be seen on an electrocardiogram (ECG) adding to the risk of serious changes in heart rhythm. On November 19, 2010, The FDA recommended that…  Read More

FDA Sets Limits on Darvon and Darvocet but Doesn't Recommend Market Withdrawal

Despite recommendations from two of its advisory committees for a phased withdrawal of propoxyphene-containing products, the Food and Drug Administration won’t be taking them off the market.  Instead they’ll require a black box warning on the label and a medication guide for patients letting them know of the serious risks of death from effects on the…  Read More